| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5183b4adbcdafef13096436ab1f0428a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1e0617130a3fa739a29d48a7f8dc17a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8fb9f44db08d1c42a53f3d28eaae416f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_48a066cdbf78bd550e3dc3eac1260d61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f83dc585bff78845d8fc48e578bc835 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J13-0065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-062 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-37 |
| filingDate |
2010-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0325cbb7fb580865f0b429ab7ec4910f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8aa14dfea94ed02fdee90c690f5455c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a61fece77446795ba197c835e568fee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42c7f3f5990fdf77d2d5bd12d564d598 |
| publicationDate |
2011-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011077674-A1 |
| titleOfInvention |
Hydrogel particles |
| abstract |
Disclosed are hydrogel particles, each of which comprises a continuous phase composed of a non-crosslinked hydrogel and a dispersed phase dispersed in the continuous phase. The dispersed phase comprises a solid fat having an organic value (OV) of 310 or greater and an inorganic value (IV) of 130 or greater in an organic conceptual diagram and a crystalline organic ultraviolet ray absorber. The crystalline organic ultraviolet ray absorber is contained in the dispersed phase in an amount of 15 to 70 mass%. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013194033-A |
| priorityDate |
2009-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |